These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 38721017)
1. A 3D pseudo-continuous arterial spin labeling study of altered cerebral blood flow correlation networks in mild cognitive impairment and Alzheimer's disease. Li M; Zhu T; Kang Y; Qi S Front Aging Neurosci; 2024; 16():1345251. PubMed ID: 38721017 [TBL] [Abstract][Full Text] [Related]
2. Relationship between Cerebral Perfusion on Arterial Spin Labeling (ASL) MRI with Brain Volumetry and Cognitive Performance in Mild Cognitive Impairment and Dementia due to Alzheimer's Disease. Soman S; Raghavan S; Rajesh PG; Varma RP; Mohanan N; Ramachandran SS; Thomas B; Kesavadas C; Menon RN Ann Indian Acad Neurol; 2021; 24(4):559-565. PubMed ID: 34728951 [TBL] [Abstract][Full Text] [Related]
3. The correlation between changes in gray matter microstructure and cerebral blood flow in Alzheimer's disease. Niu X; Guo Y; Chang Z; Li T; Chen Y; Zhang X; Ni H Front Aging Neurosci; 2023; 15():1205838. PubMed ID: 37333456 [TBL] [Abstract][Full Text] [Related]
4. Longitudinal Cerebral Blood Flow Changes in Normal Aging and the Alzheimer's Disease Continuum Identified by Arterial Spin Labeling MRI. Camargo A; Wang Z; J Alzheimers Dis; 2021; 81(4):1727-1735. PubMed ID: 33967053 [TBL] [Abstract][Full Text] [Related]
5. Pattern of cerebral hyperperfusion in Alzheimer's disease and amnestic mild cognitive impairment using voxel-based analysis of 3D arterial spin-labeling imaging: initial experience. Ding B; Ling HW; Zhang Y; Huang J; Zhang H; Wang T; Yan FH Clin Interv Aging; 2014; 9():493-500. PubMed ID: 24707173 [TBL] [Abstract][Full Text] [Related]
6. Alterations of Cerebral Blood Flow and its Connectivity Patterns Measured with Arterial Spin Labeling in Mild Cognitive Impairment. Qiu M; Zhou D; Zhu H; Shao Y; Li Y; Wang Y; Zong G; Xi Q Curr Alzheimer Res; 2023; 20(8):567-576. PubMed ID: 37921165 [TBL] [Abstract][Full Text] [Related]
7. Hypo- and hyper-perfusion in MCI and AD identified by different ASL MRI sequences. Camargo A; Wang Z; Brain Imaging Behav; 2023 Jun; 17(3):306-319. PubMed ID: 36973476 [TBL] [Abstract][Full Text] [Related]
8. Three-dimensional pseudocontinuous arterial spin labeling and susceptibility-weighted imaging associated with clinical progression in amnestic mild cognitive impairment and Alzheimer's disease. Huang Q; Cao X; Chai X; Wang X; Xu L; Xiao C Medicine (Baltimore); 2019 Jun; 98(23):e15972. PubMed ID: 31169728 [TBL] [Abstract][Full Text] [Related]
9. Cerebral blood flow measured with 3D pseudocontinuous arterial spin-labeling MR imaging in Alzheimer disease and mild cognitive impairment: a marker for disease severity. Binnewijzend MA; Kuijer JP; Benedictus MR; van der Flier WM; Wink AM; Wattjes MP; van Berckel BN; Scheltens P; Barkhof F Radiology; 2013 Apr; 267(1):221-30. PubMed ID: 23238159 [TBL] [Abstract][Full Text] [Related]
10. Cerebral Blood Flow Predicts Conversion of Mild Cognitive Impairment into Alzheimer's Disease and Cognitive Decline: An Arterial Spin Labeling Follow-up Study. Duan W; Zhou GD; Balachandrasekaran A; Bhumkar AB; Boraste PB; Becker JT; Kuller LH; Lopez OL; Gach HM; Dai W J Alzheimers Dis; 2021; 82(1):293-305. PubMed ID: 34024834 [TBL] [Abstract][Full Text] [Related]
11. Reliability of two-dimensional and three-dimensional pseudo-continuous arterial spin labeling perfusion MRI in elderly populations: comparison with 15O-water positron emission tomography. Kilroy E; Apostolova L; Liu C; Yan L; Ringman J; Wang DJ J Magn Reson Imaging; 2014 Apr; 39(4):931-9. PubMed ID: 24038544 [TBL] [Abstract][Full Text] [Related]
13. Abnormal cortical networks in mild cognitive impairment and Alzheimer's disease. Yao Z; Zhang Y; Lin L; Zhou Y; Xu C; Jiang T; PLoS Comput Biol; 2010 Nov; 6(11):e1001006. PubMed ID: 21124954 [TBL] [Abstract][Full Text] [Related]
14. Quantitative Study of the Changes in Cerebral Blood Flow and Iron Deposition During Progression of Alzheimer's Disease. Li D; Liu Y; Zeng X; Xiong Z; Yao Y; Liang D; Qu H; Xiang H; Yang Z; Nie L; Wu PY; Wang R J Alzheimers Dis; 2020; 78(1):439-452. PubMed ID: 32986675 [TBL] [Abstract][Full Text] [Related]
15. Potential Diagnostic Applications of Multi-Delay Arterial Spin Labeling in Early Alzheimer's Disease: The Chinese Imaging, Biomarkers, and Lifestyle Study. Sun M; Wang YL; Li R; Jiang J; Zhang Y; Li W; Zhang Y; Jia Z; Chappell M; Xu J Front Neurosci; 2022; 16():934471. PubMed ID: 35937865 [TBL] [Abstract][Full Text] [Related]
16. Microstructural and Cerebral Blood Flow Abnormalities in Subjective Cognitive Decline Plus: Diffusional Kurtosis Imaging and Three-Dimensional Arterial Spin Labeling Study. Yang Z; Rong Y; Cao Z; Wu Y; Zhao X; Xie Q; Luo M; Liu Y Front Aging Neurosci; 2021; 13():625843. PubMed ID: 33597860 [No Abstract] [Full Text] [Related]
17. Effects of the Fasting-Postprandial State on Arterial Spin Labeling MRI-Based Cerebral Perfusion Quantification in Alzheimer's Disease. Li R; Zhuo Z; Hong Y; Yao Z; Li Z; Wang Y; Jiang J; Wang L; Jia Z; Sun M; Zhang Y; Li W; Ren Q; Zhang Y; Duan Y; Liu Y; Wei H; Zhang Y; Chappell M; Shi H; Liu Y; Xu J J Magn Reson Imaging; 2024 Nov; 60(5):2173-2183. PubMed ID: 38544434 [TBL] [Abstract][Full Text] [Related]
18. Differentiation of Alzheimer's Disease from Frontotemporal Dementia and Mild Cognitive Impairment Based on Arterial Spin Labeling Magnetic Resonance Imaging: A Pilot Cross-Sectional Study from PUMCH Dementia Cohort. Mao C; You H; Hou B; Chu S; Jin W; Huang X; Shang L; Feng F; Peng B; Gao J J Alzheimers Dis; 2023; 93(2):509-519. PubMed ID: 37038812 [TBL] [Abstract][Full Text] [Related]
19. Cerebral blood flow changes induced by high-frequency repetitive transcranial magnetic stimulation combined with cognitive training in Alzheimer's disease. Qin Y; Ba L; Zhang F; Jian S; Zhang M; Zhu W Front Neurol; 2023; 14():1037864. PubMed ID: 36761347 [TBL] [Abstract][Full Text] [Related]
20. Discriminative Power of Arterial Spin Labeling Magnetic Resonance Imaging and 18F-Fluorodeoxyglucose Positron Emission Tomography Changes for Amyloid-β-Positive Subjects in the Alzheimer's Disease Continuum. Tosun D; Schuff N; Jagust W; Weiner MW; Neurodegener Dis; 2016; 16(1-2):87-94. PubMed ID: 26560336 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]